Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma
European Journal of Endocrinology · 2025
DOI: 10.1093/ejendo/lvae168 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2025. Verfasst von Michele Morfouace und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Head and Neck Neoplasms, Endocrine System Diseases, Cancer Survivors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stichting Kinderen Kankervrij.
Abstract (Originalsprache)
Objective
Survivors of pediatric head and neck rhabdomyosarcoma (HNRMS) are at risk of developing endocrinopathies following local treatment, resulting from radiation damage to the pituitary gland, hypothalamus, or thyroid gland, often at a young age. Our aim was to determine the prevalence of endocrine dysfunction in long-term HNRMS survivors and compare the prevalence of anterior pituitary insufficiency (API) among different local treatment strategies: external beam radiation with photons, external beam radiation with protons, microscopically radical surgery combined with external irradiation, and macroscopic radical surgery combined with brachytherapy. Design and methods Head and neck rhabdomyosarcoma survivors treated between 1993 and 2017, with ≥2 years of follow-up, without recurrent disease or secondary malignancy were eligible for this study. The presence of any endocrine dysfunction was assessed cross-sectionally using Common Terminology Criteria of Adverse Events grading, anthropometrics, and biochemical testing. Retrospective chart review was added to this clinical assessment.
Results
Ninety-six survivors with long follow-up time (median, 9 years) were included. Any endocrinopathy was present in 35% of survivors, with 88% having pituitary, 6% peripheral (thyroid), and 6% combined insufficiencies. None had gonadal insufficiency. Growth hormone deficiency was diagnosed in 31 (32%) survivors, with additional pituitary insufficiencies in 12 (39%). In 8%, central precocious puberty preceded API. None of the survivors given brachytherapy had API.
Conclusions
The prevalence of pituitary dysfunction in HNRMS survivors is high, emphasizing the importance of systematic endocrine assessment during follow-up, including pubertal development and growth. Efforts should be made to further reduce extraneous irradiation to endocrine organs to prevent dysfunction later in life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
- Department of Otorhinolaryngology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
- Department of Pediatric and Adolescent Oncology, Gustave Roussy, 94805 Villejuif, France.
- Department of Plastic Surgery, Gustave Roussy, 94805 Villejuif, France.
- Department of Radiotherapy, Gustave Roussy, 94805 Villejuif, France.
- Department of Biometrics, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
ORCID-Profile: Michele Morfouace, Eric Sandler
Förderung
- Stichting Kinderen Kankervrij
Zitieren
APA
Morfouace, M., Schoot, R. A., Hol, M. L. F., Minard-Colin, V., Kolb, F., Bollé, S., Kayembe, M. T., Gaze, M. N., Sandler, E., Knops, R. R. G., Merks, J. H. M., Smeele, L. E., Indelicato, D. J., Slater, O., & van Santen, H. M. (2025). Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae168
Vancouver
Morfouace M, Schoot RA, Hol MLF, Minard-Colin V, Kolb F, Bollé S, et al. Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma. European Journal of Endocrinology. 2025. doi:10.1093/ejendo/lvae168
BibTeX
@article{Morfouace2025,
author = {Morfouace, Michele and Schoot, Reineke A and Hol, Marinka L F and Minard-Colin, Veronique and Kolb, Frederic and Bollé, Stephanie and Kayembe, Matumba T and Gaze, Mark N and Sandler, Eric and Knops, Rutger R G and Merks, Johannes H M and Smeele, Ludwig E and Indelicato, Daniel J and Slater, Olga and van Santen, Hanneke M},
title = {Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma},
journal = {European Journal of Endocrinology},
year = {2025},
doi = {10.1093/ejendo/lvae168}
}
EUVIMED